Part 1 is mostly about what happened as Bess and I raced against tumor growth to find a new clinical trial that might keep me alive. Part 2 is mostly about how this process feels and what could be done differently—and better. I thought we were so smart and so well-prepared: Bess and I knew that, if I’m to stay alive, I’d need to swiftly pivot to another clinical trial the moment petosemtamab failed to control the eight squamous cell carcinoma tumors in my neck and lungs. Bess wrote the definitiv...